These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 35251695)
1. The development of a nomogram and the prognostic prediction value of patients with esophageal squamous cell carcinoma undergoing radical radiotherapy. Xiao L; Lyu J; Chen M; Wang L; Huang J; Wei Y; Li T Future Sci OA; 2022 Mar; 8(3):FSO781. PubMed ID: 35251695 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of Osaka prognostic score based on nutritional and inflammatory status in patients with esophageal squamous cell carcinoma. Feng J; Wang L; Wang L; Yang X; Lou G BMC Cancer; 2022 Mar; 22(1):284. PubMed ID: 35300627 [TBL] [Abstract][Full Text] [Related]
3. Comparison of clinicopathological features and survival analysis between esophageal neuroendocrine carcinoma and esophageal squamous cell carcinoma based on the SEER database, alongside nomogram analysis for esophageal neuroendocrine carcinoma. Lin Z; Chen YY; Liu CH; Panzuto F; Ramirez RA; Lang M; Kim H; Ding ZY J Gastrointest Oncol; 2023 Dec; 14(6):2309-2323. PubMed ID: 38196527 [TBL] [Abstract][Full Text] [Related]
4. Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer. Luo HS; Chen YY; Huang WZ; Wu SX; Huang SF; Xu HY; Xue RL; Du ZS; Li XY; Lin LX; Huang HC Radiat Oncol; 2021 Oct; 16(1):201. PubMed ID: 34641928 [TBL] [Abstract][Full Text] [Related]
5. Survival and prognostic factors in patients with synchronous multiple primary esophageal squamous cell carcinoma receiving definitive radiotherapy: A propensity score-matched analysis. Wang W; Liu X; Dang J; Li G Front Oncol; 2023; 13():1132423. PubMed ID: 37035207 [TBL] [Abstract][Full Text] [Related]
7. Clinical Application Value of the Prognostic Nutritional Index for Predicting Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy or Radiotherapy. Xiao L; Lyu J; Liu X; Li K; Wang Y; Zhang R; Chen T; Li T Nutr Cancer; 2021; 73(10):1933-1940. PubMed ID: 33044092 [TBL] [Abstract][Full Text] [Related]
8. Nomogram constructed by immunological and inflammatory indicators for predicting prognosis of patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy plus surgery. Luo Y; Weng XF; Huang JT; Hu XH; Wei LF; Lin YW; Ding TY; Zhang B; Chu LY; Liu CT; Peng YH; Xu YW; Wu FC Front Oncol; 2022; 12():882900. PubMed ID: 35965555 [TBL] [Abstract][Full Text] [Related]
9. A new risk score model based on lactate dehydrogenase for predicting prognosis in esophageal squamous cell carcinoma treated with chemoradiotherapy. Liu C; Han J; Han D; Huang W; Li B J Thorac Dis; 2023 Apr; 15(4):2116-2128. PubMed ID: 37197526 [TBL] [Abstract][Full Text] [Related]
10. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer. Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507 [TBL] [Abstract][Full Text] [Related]
11. A nomogram for the predicting of survival in patients with esophageal squamous cell carcinoma undergoing definitive chemoradiotherapy. Wang P; Yang M; Wang X; Zhao Z; Li M; Yu J Ann Transl Med; 2021 Feb; 9(3):233. PubMed ID: 33708860 [TBL] [Abstract][Full Text] [Related]
12. Nomogram to Predict Overall Survival for Thoracic Esophageal Squamous Cell Carcinoma Patients After Radical Esophagectomy. Deng W; Zhang W; Yang J; Ni W; Yu S; Li C; Chang X; Zhou Z; Chen D; Feng Q; Chen X; Lin Y; Zhu K; Zheng X; He J; Gao S; Xue Q; Mao Y; Cheng G; Sun K; Liu X; Fang D; Chen J; Xiao Z Ann Surg Oncol; 2019 Sep; 26(9):2890-2898. PubMed ID: 31183641 [TBL] [Abstract][Full Text] [Related]
13. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma. Li W; Liu J; Zhao H Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896 [TBL] [Abstract][Full Text] [Related]
14. Clinical utility of the systemic immune-inflammation index for predicting survival in esophageal squamous cell carcinoma after radical radiotherapy. Wang Y; Lyu J; Jia H; Liang L; Xiao L; Liu Y; Liu X; Li K; Chen T; Zhang R; Zhang H; Tang C; Li T Future Oncol; 2021 Jul; 17(20):2647-2657. PubMed ID: 34008415 [TBL] [Abstract][Full Text] [Related]
15. Nomogram-Integrated C-Reactive Protein/Albumin Ratio Predicts Efficacy And Prognosis In Patients With Thoracic Esophageal Squamous Cell Carcinoma Receiving Chemoradiotherapy. Zhang H; Guo XW; Yin XX; Liu YC; Ji SJ Cancer Manag Res; 2019; 11():9459-9468. PubMed ID: 31819611 [TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a Nomogram for Predicting Overall Survival to Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma. Wang C; Cheng X; Jin L; Ren R; Wang S; Zheng A; Hao A; Zhou F; Zhang Y Biomed Res Int; 2022; 2022():6455555. PubMed ID: 35872847 [TBL] [Abstract][Full Text] [Related]
17. A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery. Ding T; Liu C; Huang B; Chu L; Wei L; Lin Y; Luo Y; Zhang B; Hong C; Xu Y; Peng Y Cancer Manag Res; 2021; 13():7771-7782. PubMed ID: 34675672 [TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Prognostic Nomogram for Hypopharyngeal Carcinoma. Tian S; Li Q; Li R; Chen X; Tao Z; Gong H; Wang X; Hu X Front Oncol; 2021; 11():696952. PubMed ID: 34235086 [TBL] [Abstract][Full Text] [Related]
19. Identification of Epithelial-Mesenchymal Transition- (EMT-) Related LncRNA for Prognostic Prediction and Risk Stratification in Esophageal Squamous Cell Carcinoma. Wang P; Chen Y; Zheng Y; Fu Y; Ding Z Dis Markers; 2021; 2021():5340240. PubMed ID: 34712369 [TBL] [Abstract][Full Text] [Related]
20. Development of a prognostic nomogram for esophageal squamous cell carcinoma patients received radiotherapy based on clinical risk factors. Li Y; Shao X; Dai LJ; Yu M; Cong MD; Sun JY; Pan S; Shi GF; Zhang AD; Liu H Front Oncol; 2024; 14():1429790. PubMed ID: 39239271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]